Novo Nordisk A/S NVO | NYSE
After Hours
Next Earnings: Aug 06, 2025
Company Overview:
10 Year NVO Performance Metrics:
NVO Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
NVO Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
NVO Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
NVO Dividends Info:
NVO Dividend History: Dates, Payments & Yield list
Below is a schedule of all NVO dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 03/31/2025 | 04/08/2025 | $1.099 | 2.32% | 3.57% | $61.60 |
| 08/16/2024 | 08/26/2024 | $0.513 | 1.07% | 0.76% | $135.30 |
| 03/22/2024 | 04/02/2024 | $0.930 | 1.07% | 1.47% | $126.46 |
| 08/18/2023 | 08/29/2023 | $0.442 | 1.13% | 0.93% | $95.18 |
| 03/24/2023 | 04/04/2023 | $0.595 | 1.16% | 1.5% | $79.29 |
| 08/12/2022 | 08/23/2022 | $0.584 | 3.01% | 2.19% | $53.29 |
| 03/25/2022 | 04/05/2022 | $1.036 | 2.99% | 3.61% | $57.40 |
| 08/16/2021 | 08/25/2021 | $0.557 | 2.92% | 2.15% | $51.81 |
| 03/26/2021 | 04/07/2021 | $0.949 | 4.33% | 5.59% | $33.95 |
| 08/14/2020 | 08/25/2020 | $0.518 | 3.96% | 3.12% | $33.23 |
| 03/27/2020 | 04/07/2020 | $0.783 | 4.34% | 5.35% | $29.27 |
| 08/16/2019 | 08/27/2019 | $0.449 | 4.79% | 3.44% | $26.08 |
| 03/22/2019 | 04/02/2019 | $0.789 | 4.95% | 6.06% | $26.05 |
| 08/17/2018 | 08/28/2018 | $0.467 | 4.79% | 3.76% | $24.83 |
| 03/23/2018 | 04/03/2018 | $0.670 | 4.72% | 5.45% | $24.57 |
| 08/17/2017 | 08/29/2017 | $0.474 | 5.02% | 4.07% | $23.25 |
| 03/23/2017 | 04/04/2017 | $0.663 | 6.7% | 7.36% | $18.02 |
| 08/11/2016 | 08/23/2016 | $0.447 | 6.07% | 3.77% | $23.71 |
| 03/18/2016 | 03/30/2016 | $0.964 | 6.31% | 7.11% | $27.13 |
| 03/19/2015 | 03/31/2015 | $0.760 | 6.6% | 5.69% | $26.70 |
| 03/21/2014 | 04/02/2014 | $0.830 | 3.78% | 7.3% | $22.76 |
| 03/21/2013 | 04/02/2013 | $0.637 | 7.05% | 7.75% | $16.43 |
| 03/22/2012 | 04/03/2012 | $0.499 | 6.09% | 6.69% | $14.93 |
| 03/24/2011 | 04/05/2011 | $0.364 | 5.24% | 5.7% | $12.76 |
| 03/08/2007 | 03/20/2007 | $0.122 | 5.2% | 5.59% | $4.36 |
| 03/19/2009 | 11/30/-0001 | $0.207 | 4.49% | 8.97% | $4.61 |
| 04/26/1994 | 11/30/-0001 | $0.006 | 2.07% | 2.07% | $0.54 |
| 04/22/1994 | 11/30/-0001 | $0.006 | 1.06% | 2.11% | $0.53 |
| 04/22/1993 | 11/30/-0001 | $0.005 | 2.53% | 2.4% | $0.45 |
| 04/28/1992 | 11/30/-0001 | $0.006 | 1.46% | 2.93% | $0.41 |
| 04/19/1991 | 11/30/-0001 | $0.005 | 3.54% | 3.18% | $0.32 |
| 04/23/1990 | 11/30/-0001 | $0.006 | 2.84% | 5.67% | $0.22 |
| 04/21/1989 | 11/30/-0001 | $0.005 | 2.2% | 4.41% | $0.21 |
| 04/21/1988 | 11/30/-0001 | $0.005 | 3.73% | 7.46% | $0.14 |
| 04/20/1987 | 11/30/-0001 | $0.004 | 3.99% | 4.36% | $0.19 |
| 04/21/1986 | 11/30/-0001 | $0.003 | 2.02% | 4.05% | $0.17 |
| 04/19/1985 | 11/30/-0001 | $0.003 | 1.99% | 3.98% | $0.13 |
| 04/13/1984 | 11/30/-0001 | $0.003 | 1.2% | 2.4% | $0.24 |
| 04/13/1983 | 11/30/-0001 | $0.003 | 1.28% | 2.11% | $0.26 |
| 04/24/1995 | 11/30/-0001 | $0.008 | 2.75% | 3.29% | $0.51 |
| 04/24/1996 | 11/30/-0001 | $0.007 | 1.11% | 2.22% | $0.65 |
| 05/01/1996 | 11/30/-0001 | $0.009 | 2.39% | 2.61% | $0.66 |
| 03/13/2008 | 11/30/-0001 | $0.177 | 2.57% | 5.15% | $6.87 |
| 03/25/2010 | 11/30/-0001 | $0.281 | 3.59% | 7.19% | $7.83 |
| 03/09/2006 | 11/30/-0001 | $0.097 | 6.16% | 6.59% | $2.93 |
| 03/10/2005 | 11/30/-0001 | $0.084 | 5.58% | 5.92% | $2.84 |
| 03/17/2004 | 11/30/-0001 | $0.075 | 5.51% | 6.48% | $2.30 |
| 03/26/2003 | 11/30/-0001 | $0.052 | 3.13% | 6.26% | $1.67 |
| 03/13/2002 | 11/30/-0001 | $0.037 | 3.6% | 3.86% | $1.91 |
| 03/21/2001 | 11/30/-0001 | $0.032 | 2.54% | 3.2% | $1.99 |
| 11/17/2000 | 11/30/-0001 | $0.019 | 2.32% | 2.07% | $1.82 |
| 03/24/2000 | 11/30/-0001 | $0.023 | 2.82% | 3.32% | $1.41 |
| 03/25/1999 | 11/30/-0001 | $0.016 | 3.25% | 3.28% | $1.00 |
| 03/27/1998 | 11/30/-0001 | $0.016 | 1.71% | 2.01% | $1.60 |
| 04/25/1997 | 11/30/-0001 | $0.011 | 1.96% | 2.23% | $1.01 |
| 04/23/1982 | 11/30/-0001 | $0.001 | 0.29% | 0.57% | $0.21 |
Projected Future Returns & Dividends for NVO
Based on past 10-year performance, here are NVO growth metrics:
Share price CAGR of +8.17%
Dividend CAGR of +3.76%
Using NVO CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| NVO (DRIP) | NVO - No DRIP | |
|---|---|---|
| Current Price | $64.31 | $64.31 |
| Start Shares | 155.50 | 155.50 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 274.09 | 155.50 |
| Dividends Payment | $1.59 | $1.59 |
| Annual Dividends | $1,743 | $989 |
| Yield on cost | 17.43% | 9.89% |
| Share Price | $130.40 | $130.40 |
| Total Dividends | $11,244 | $8,117 |
| Final Value | $35,742 | $28,394 |
NOTE: Above numbers are our estimate based on NVO's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
Novo Nordisk A/S (NVO) had its IPO on 1981-04-30, and is trader on NYSE stock exchange.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
NVO website: https://www.novonordisk.com
